Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Extracellular Vesicles Enriched in Connexin 43 Promote a Senescent Phenotype in Bone and Synovial Cells Contributing to Osteoarthritis Progression

  • Varela-Eirín, Marta
  • Carpintero-Fernández, Paula
  • Guitián-Caamaño, Amanda
  • Varela Vázquez, Adrián
  • García-Yuste, Alejandro
  • Sánchez-Temprano, Agustín
  • Bravo López, Susana Belén
  • Yáñez-Cabanas, José
  • Fonseca, Eduardo
  • Largo, R
  • Mobasheri, Ali
  • Caeiro, José Ramón
  • Mayán, María D.
[Abstract] The accumulation of senescent cells is a key characteristic of aging, leading to the progression of age-related diseases such as osteoarthritis (OA). Previous data from our laboratory has demonstrated that high levels of the transmembrane protein connexin 43 (Cx43) are associated with a senescent phenotype in chondrocytes from osteoarthritic cartilage. OA has been reclassified as a musculoskeletal disease characterized by the breakdown of the articular cartilage affecting the whole joint, subchondral bone, synovium, ligaments, tendons and muscles. However, the mechanisms that contribute to the spread of pathogenic factors throughout the joint tissues are still unknown. Here, we show for the first time that small extracellular vesicles (sEVs) released by human OA-derived chondrocytes contain high levels of Cx43 and induce a senescent phenotype in targeted chondrocytes, synovial and bone cells contributing to the formation of an inflammatory and degenerative joint environment by the secretion of senescence-associated secretory associated phenotype (SASP) molecules, including IL-1ß and IL-6 and MMPs. The enrichment of Cx43 changes the protein profile and activity of the secreted sEVs. Our results indicate a dual role for sEVs containing Cx43 inducing senescence and activating cellular plasticity in target cells mediated by NF-kß and the extracellular signal-regulated kinase 1/2 (ERK1/2), inducing epithelial-to-mesenchymal transition (EMT) signalling programme and contributing to the loss of the fully differentiated phenotype. Our results demonstrated that Cx43-sEVs released by OA-derived chondrocytes spread senescence, inflammation and reprogramming factors involved in wound healing failure to neighbouring tissues, contributing to the progression of the disease among cartilage, synovium, and bone and probably from one joint to another. These results highlight the importance for future studies to consider sEVs positive for Cx43 as a new biomarker of disease progression and new target to treat OA., This work was supported in part through funding from Health Institute ‘Carlos III’ (ISCIII, Spain), the European Regional Development Fund, ‘A way of making Europe’ from the European Union (to MDM): grant PI19/00145; a grant from the Joint Transnational Call for Proposals for “European Innovative Research & Technological Development Projects in Nanomedicine” EURONANOMED III (AC21_2/00026) (to MDM); a grant from Xunta de Galicia (IN607B2020/12) (to MDM) and from H2020, Future and Emerging Technologies (grant 858014 “PANACHE”) to MDM. MV-E was funded with a predoctoral (ED481A-2015/188) and post-doctoral fellowship (IN606B-2019/004) from Xunta de Galicia. AG-C was funded with a predoctoral fellowship (FIS20/00310) from ISCIII. PC-F was funded with a post-doctoral fellowship and a grant from Xunta de Galicia (INB606B 2017/014 and IN606C 2021/006). We thank members of the CellCOM group for helpful technical suggestion, María Dolores Álvarez Alvariño (CHUS) for generously collecting tissue samples in the operating room after surgery and Arantxa Tabernero (INCYL, University of Salamanca) for kindly providing the human Cx43 plasmid used in this study, Xunta de Galicia; IN607B2020/12, Xunta de Galicia; ED481A-2015/188, Xunta de Galicia; IN606B-2019/004, Xunta de Galicia; INB606B 2017/014, Xunta de Galicia; IN606C 2021/006
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Coherent silicon photonic interferometric biosensor with an inexpensive laser source for sensitive label-free immunoassays

  • Leuermann, Jonas
  • Stamenkovic, Vladimir
  • Ramirez-Priego, Patricia
  • Sánchez Postigo, Alejandro
  • Fernández Gavela, Adrián
  • Chapman, Cole A.
  • Bailey, Ryan C.
  • Lechuga, Laura M.
  • Pérez-Inestrosa, Ezequiel
  • Collado, Daniel
  • Halir, Robert
  • Molina Fernández, Íñigo
Over the past two decades, integrated photonic sensors have been of major interest to the optical biosensor community due to their capability to detect low concentrations of molecules with label-free operation. Among these, interferometric sensors can be read-out with simple, fixed-wavelength laser sources and offer excellent detection limits but can suffer from sensitivity fading when not tuned to their quadrature point. Recently, coherently detected sensors were demonstrated as an attractive alternative to overcome this limitation. Here we show, for the first time, to the best of our knowledge, that this coherent scheme provides sub-nanogram per milliliter limits of detection in C-reactive protein immunoassays and that quasi-balanced optical arm lengths enable operation with inexpensive Fabry–Perot-type lasers sources at telecom wavelengths., Horizon 2020 Framework Programme (EuroNanoMed 3-H2020 DrNanoDAII); Ministerio de Economía y Competitividad (2019/PCI 2019-2, CTQ2017-86994-R, SEV-2017-0706); Junta de Andalucía, Proyectos Excelencia-Retos (P18-RT-1453, P18-RT-793); Fondos Europeos de Desarrollo Regional (CTQ2016-75870-P, PID2019-104293GB-I00, RD16/0006/0012, TEC2016-80718-R, UMA18-FEDERJA-007, UMA18-FEDERJA-219); H2020 Marie Skłodowska-Curie Actions (713721)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Malaria quantitative POC testing using magnetic particles, a paper microfluidic device and a hand-held fluorescence reader

  • Arias-Alpízar, K.
  • Sánchez-Cano, A.
  • Prat-Trunas, J.
  • Serna Serna, E. de la
  • Alonso, O.
  • Sulleiro, E.
  • Sánchez-Montalvá, A.
  • Diéguez, A.
  • Baldrich, Eva
A point-of-care (POC) device is reported for highly sensitive and selective detection of Plasmodium falciparum lactate dehydrogenase (Pf-LDH), a biomarker of malaria infection, based on a single-step magneto-immunoassay, a single-use microfluidic paper device and a customized hand-held fluorescence reader. The single-step magneto-immunoassay consists in a single 5-min incubation of immuno-modified magnetic particles (c-MAb-MPs), biotinylated detection antibody (bd-MAb), and an enzymatic signal amplifier (Poly-HRP). After on-chip MP concentration and washing, signal generation is achieved by adding a fluorescent enzymatic substrate (QuantaRed). Fluorescence signal is measured using a low-cost customized, portable, and sensible fluorescent detector. The POC affords quantitative Pf-LDH detection in <20 min, with a detection limit of 0.92 ng mL−1 (equivalent to 4.6 parasites μL−1). Furthermore, Pf-LDH quantitation in clinical samples correlates with that provided by the reference ELISA, is more sensitive than a commercial rapid diagnostic test (RDT) and entails little user intervention. These results show that fluorescent paper-based microfluidic devices can be exploited to simplify magneto-immunoassay handling, taking this type of test closer to the requirements of POC testing., This work was supported by Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (grants CPII18/00025, IFI18/00020 and QUPID EuroNanoMed AC21_2/00021). KAA is supported by an InPHINIT fellowship from “La Caixa” Foundation (LCF/BQ/DI18/11660061). ASM is supported by a Juan Rodés postdoctoral fellowship from ISCIII (JR18/00022). Diagnostic Nanotools is an AGAUR Consolidated Group (2017 SGR 240)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

NANO4STROKE – Data Management Plan (DMP), Data Management Plan NANO4STROKE. ISCiii: AC20/00052 2001-2004

  • Planas, Anna M.
  • Justicia, Carles
  • Petegnief, Valérie
Instituto de Salud Carlos III.-- Euronanomed III.-- Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), The Data Management Plan (DMP) for the NANO4STROKE project is prepared to provide an analysis of the main elements of the data management policy that will be used by the consortium with regard to the project research data. The DMP covers the complete research data life cycle concerning data generated by the IDIBAPS team (P4 in the European consortium). It describes the types of research data that will be generated or collected during the project, the standards that will be used, how the research data will be preserved and what parts of the datasets will be shared for verification or reuse. The document helps project partners to determine how the data can be managed efficiently and effectively and reduce the risk of data loss and conflicts. The DMP is a living document and in case it will be needed, the DMP will be updated throughout the project, whenever significant changes arise, such as new data or changes in the consortium policies or consortium composition. The DMP is developed according to the FAIR principles, meaning that data should be Findable, Accessible, Interoperable, and Re-usable. The project will also comply with H2020 Open Access to publications and this DMP also gives an overview of the consortium related strategy., Euronanomed III, Joint Transnational Call for Proposals (2020) for “European Innovative Research & Technological Development Projects in Nanomedicine. This DPM is focus on data of the specific partner: P4 (IDIBAPS) financed by the ISCiii : AC20/00052, 1. General information. 2. Introduction to NANO4STROKE data management plan.3. Data description and collection or re-use of existing data. 4. Documentation and data quality. 5. Storage and backup during the research process. 6. Legal and ethical requirements, codes of conduct. 7. Data sharing and long-term preservation. 8. Data management responsibilities and resources, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

N4S / In vivo N4S Project Dataset

  • Justicia, Carles
  • Petegnief, Valérie
The summary is found on the first page of the Excel file (N4S in vivo Results) containing the results of the entire experiment. This sheet includes the coding of the treatments, and the results grouped by treatment, which include neuroscore, infarct volume and oedema, % of LDF change at occlusion and at reperfusion, and initial and final body weight. The results are compiled in an Excel document called 'N4S in vivo Results'., Nano4Stroke, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Development of immunoliposomes with E-Selectin affinity to target endothelial inflammation: direct comparison of antibody types

  • Gkartziou, Foteini
  • Petegnief, Valérie
  • Kannavou, Maria
  • Flavíán Lázaro, Cristina
  • Pascual, Nuria
  • Márquez-Kisinousky, Leonardo
  • Marco, María Pilar
  • Planas, Anna M.
  • Antimisiaris, Sophia G.
Inflamed endothelium targeting via E-Selectin is a promising strategy for drug delivery across the neurovascular interface, however, exploitation of the strategy by immunoliposomes remains limited. Furthermore, the high cost of antibodies poses a practical barrier for iterative formulation optimization. In this study, we developed two E-Selectin–targeted immunoliposome types incorporating either a commercially available monoclonal antibody (mAb) or a mAb produced in-house from a proprietary hybridoma line. Pre-formed liposomes were functionalized through maleimide-PEG conjugation and characterized for size distribution (by DLS), zeta potential (electrophoretic mobility), and Mab attachment (%). Immunoliposome targeting efficacy was assessed on brain microvascular endothelial cells under basal conditions and also after LPS-induced inflammation (to mimic pathological E-Selectin upregulation), by flow cytometry. Both immunoliposome formulations had similar characteristics and demonstrated significantly enhanced binding to endothelial cells relative to non-targeted liposomes, under both conditions studied. Furthermore, uptake by inflamed cells was always significantly higher than by non-inflamed cells. No differences in (in vitro) targeting magnitude between the commercial and hybridoma-derived Mab’s were quantified, proving their comparable performance despite substantial differences in mAb cost. The current findings highlight the feasibility of substituting commercial mAbs with hybridoma-derived ones during preclinical development of targeted nanocarriers, as a strategy to reduce expenses while preserving their specificity and functional performance. Furthermore, it is demonstrated that E-Selectin targeted immunoliposomes are promising drug delivery systems for treatment of inflamed vasculature, justifying further in vitro and in vivo exploitation., The Project ‘Nano4stroke’ was supported by the ERA-NET Program EURONANOMED III (GA N 723770 of the EU Horizon 2020 Research and Innovation Programme) and funded by the Operational Programme for Research, Entrepreneurship and Innovation 2014–2020, Greek National Research and Innovation Strategy for Smart Specialization 2014–2020 (RIS3) (Τ12ΕΡΑ5-00079), and by the Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Health (AC20/00052)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Coherent silicon photonic interferometric biosensor with an inexpensive laser source for sensitive label-free immunoassays

  • Leuermann, Jonas|||0000-0001-7321-5190
  • Stamenkovic, Vladimir
  • Ramirez Priego, Patricia|||0000-0001-5657-3279
  • Sánchez-Postigo, Alejandro|||0000-0003-4782-0105
  • Fernandez-Gavela, Adrian|||0000-0002-4562-1308
  • Chapman, Cole A.
  • Bailey, Ryan C.
  • Lechuga, Laura M.|||0000-0001-5187-5358
  • Pérez Inestrosa, Ezequiel|||0000-0001-7546-5273
  • Collado, Daniel
  • Halir, Robert|||0000-0002-5560-3189
  • Molina-Fernandez, Iñigo|||0000-0001-9596-4117
Over the past two decades, integrated photonic sensors have been of major interest to the optical biosensor community due to their capability to detect low concentrations of molecules with label-free operation. Among these, interferometric sensors can be read-out with simple, fixed-wavelength laser sources and offer excellent detection limits but can suffer from sensitivity fading when not tuned to their quadrature point. Recently, coherently detected sensors were demonstrated as an attractive alternative to overcome this limitation. Here we show, for the first time, to the best of our knowledge, that this coherent scheme provides sub-nanogram per milliliter limits of detection in C-reactive protein immunoassays and that quasi-balanced optical arm lengths enable operation with inexpensive Fabry-Perot-type lasers sources at telecom wavelengths.